Investigation of the biological significance of collapsin response mediator protein (CRMP) in breast cancer
| Project/Area Number |
23591899
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Research Field |
General surgery
|
|---|
| Research Institution | Yokohama City University |
|---|
Principal Investigator |
TAKASHI Ishikawa 横浜市立大学, 附属市民総合医療センター, 准教授 (80275049)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
千島 隆司 横浜市立大学, 医学(系)研究科(研究院), その他 (70438141)
|
|---|
| Co-Investigator(Renkei-kenkyūsha) |
五嶋 良郎
長嶋 洋治
|
|---|
| Project Period (FY) |
2011 – 2013
|
| Project Status |
Completed (Fiscal Year 2013)
|
| Budget Amount *help |
¥2,470,000 (Direct Cost: ¥1,900,000、Indirect Cost: ¥570,000)
Fiscal Year 2013: ¥520,000 (Direct Cost: ¥400,000、Indirect Cost: ¥120,000)
Fiscal Year 2012: ¥260,000 (Direct Cost: ¥200,000、Indirect Cost: ¥60,000)
Fiscal Year 2011: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
|---|
| Keywords | CRMP2 / リン酸化型CRMP2 / 乳癌 / 乳腺 / タキサン / 神経細胞軸索退縮因子 / リン酸化CRMP2 / CRMPs |
|---|
| Research Abstract |
The expression of CRMP2 mRNA was significantly decreased in breast cancer tissues, while that of the other CRMPs was similar between normal and breast cancer tissues. Immunohistochemistry revealed that CRMP2 protein expression was also decreased in breast cancer tissues (P < 0.001). Phosphorylated CRMP2 was observed in the nuclei of breast cancer cells but not in normal mammary cells (P < 0.001). Furthermore, nuclear phosphorylated CRMP2 expression was increased in proportion to the histological grade and triple-negative subtype. Reduced CRMP2 expression and elevated expression of nuclear phosphorylated CRMP2 may be associated with breast cancer progression.
|
Report
(4 results)
Research Products
(4 results)
